We showed that Nav1.7 associated with endometrial cancer development, the Nav1.7 activator veratridine reduced endometrial tumor cell apoptosis and promoted cancer invasion, and inhibition of Nav1.7 by PF-05089771 increase the number of apoptotic cells and attenuated invasive potential of cancer cells. Here, SCN9A is linked to endometrial cancer.